Atypical neuroleptic malignant syndrome associated with olanzapine
Related Experiment Video
Updated: Oct 1, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Roy R Reeves1, Raphael A Torres, Vincent Liberto
1G.V. (Sonny) Montgomery Veterans Administration Medical Center, Jackson, Mississippi 39216, USA. roy.reeves2@med.va.gov
Abstract:
Neuroleptic malignant syndrome (NMS) is a potentially life-threatening adverse effect of antipsychotic agents. It generally is characterized by fever, altered mental status, rigidity, and autonomic dysfunction. A 53-year-old man developed NMS without rigidity while taking olanzapine. Such atypical cases may support either a spectrum concept of NMS or the theory that NMS secondary to atypical antipsychotics differs from that caused by conventional neuroleptics. More flexible diagnostic criteria than currently mandated by the the Diagnostic and Statistical Manual of Mental Disorders, Fourth Revision, may be warranted.
Insights
Neuroleptic malignant syndrome (NMS), a severe antipsychotic reaction, can occur without muscle rigidity. This case highlights atypical presentations, suggesting NMS may exist on a spectrum or differ with newer drugs.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Neuroleptic malignant syndrome (NMS) is a critical adverse drug reaction associated with antipsychotic medications.
- Typical NMS presentation includes fever, altered mental status, muscle rigidity, and autonomic instability.
- Antipsychotic agents are widely used for treating various psychiatric conditions.
Observation:
- A 53-year-old male patient developed NMS while being treated with olanzapine, an atypical antipsychotic.
- The patient presented with NMS symptoms but notably lacked muscle rigidity.
- This atypical presentation challenges conventional diagnostic criteria for NMS.
Findings:
- The absence of rigidity in this NMS case suggests a broader spectrum of the syndrome.
- Atypical antipsychotics like olanzapine may induce NMS with distinct clinical features compared to conventional neuroleptics.
- This case provides evidence supporting the theory that NMS secondary to atypical antipsychotics differs from that caused by older agents.
Implications:
- Current diagnostic criteria for NMS, such as those in the DSM-IV, may be too restrictive.
- More flexible diagnostic guidelines are needed to accurately identify all cases of NMS, especially those with atypical features.
- Recognizing atypical NMS presentations is crucial for timely diagnosis and management, potentially improving patient outcomes.
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis: Goals of Pharmacotherapy
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Mania and Antimanic Drugs: Overview